Literature DB >> 27426413

Net reclassification index at event rate: properties and relationships.

Michael J Pencina1, Ewout W Steyerberg2, Ralph B D'Agostino3.   

Abstract

The net reclassification improvement (NRI) is an attractively simple summary measure quantifying improvement in performance because of addition of new risk marker(s) to a prediction model. Originally proposed for settings with well-established classification thresholds, it quickly extended into applications with no thresholds in common use. Here we aim to explore properties of the NRI at event rate. We express this NRI as a difference in performance measures for the new versus old model and show that the quantity underlying this difference is related to several global as well as decision analytic measures of model performance. It maximizes the relative utility (standardized net benefit) across all classification thresholds and can be viewed as the Kolmogorov-Smirnov distance between the distributions of risk among events and non-events. It can be expressed as a special case of the continuous NRI, measuring reclassification from the 'null' model with no predictors. It is also a criterion based on the value of information and quantifies the reduction in expected regret for a given regret function, casting the NRI at event rate as a measure of incremental reduction in expected regret. More generally, we find it informative to present plots of standardized net benefit/relative utility for the new versus old model across the domain of classification thresholds. Then, these plots can be summarized with their maximum values, and the increment in model performance can be described by the NRI at event rate. We provide theoretical examples and a clinical application on the evaluation of prognostic biomarkers for atrial fibrillation.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  decision analysis; net benefit; reclassification; regret; utility

Mesh:

Year:  2016        PMID: 27426413     DOI: 10.1002/sim.7041

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  35 in total

1.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

2.  Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction.

Authors:  Jennifer J Stuart; Lauren J Tanz; Nancy R Cook; Donna Spiegelman; Stacey A Missmer; Eric B Rimm; Kathryn M Rexrode; Kenneth J Mukamal; Janet W Rich-Edwards
Journal:  J Am Coll Cardiol       Date:  2018-09-11       Impact factor: 24.094

3.  Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.

Authors:  Olga V Demler; Michael J Pencina; Nancy R Cook; Ralph B D'Agostino
Journal:  Stat Med       Date:  2017-06-19       Impact factor: 2.373

4.  First things first: risk model performance metrics should reflect the clinical application.

Authors:  Kathleen F Kerr; Holly Janes
Journal:  Stat Med       Date:  2017-12-10       Impact factor: 2.373

5.  Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.

Authors:  Stephen R Williams; Fang-Chi Hsu; Keith L Keene; Wei-Min Chen; Godfrey Dzhivhuho; Joe L Rowles; Andrew M Southerland; Karen L Furie; Stephen S Rich; Bradford B Worrall; Michèle M Sale
Journal:  Stroke       Date:  2017-05-11       Impact factor: 7.914

6.  Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

Authors:  Benjamin M Scirica; Ofri Mosenzon; Deepak L Bhatt; Jacob A Udell; Ph Gabriel Steg; Darren K McGuire; KyungAh Im; Estella Kanevsky; Christina Stahre; Mikaela Sjöstrand; Itamar Raz; Eugene Braunwald
Journal:  JAMA Cardiol       Date:  2018-02-01       Impact factor: 14.676

7.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.

Authors:  Joshua Elliott; Barbara Bodinier; Tom A Bond; Marc Chadeau-Hyam; Evangelos Evangelou; Karel G M Moons; Abbas Dehghan; David C Muller; Paul Elliott; Ioanna Tzoulaki
Journal:  JAMA       Date:  2020-02-18       Impact factor: 56.272

8.  Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.

Authors:  Nicholas A Marston; Marc P Bonaca; Petr Jarolim; Erica L Goodrich; Deepak L Bhatt; Philippe G Steg; Marc Cohen; Robert F Storey; Per Johanson; Stephen D Wiviott; Eugene Braunwald; Marc S Sabatine; David A Morrow
Journal:  JAMA Cardiol       Date:  2020-11-01       Impact factor: 14.676

9.  The summary test tradeoff: a new measure of the value of an additional risk prediction marker.

Authors:  Stuart G Baker
Journal:  Stat Med       Date:  2017-12-10       Impact factor: 2.373

Review 10.  Clinical risk reclassification at 10 years.

Authors:  Nancy R Cook; Olga V Demler; Nina P Paynter
Journal:  Stat Med       Date:  2017-12-10       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.